# De Novo Lipogenesis in Severity of NAFLD

> **NCT03683589** · — · COMPLETED · sponsor: **University of Missouri-Columbia** · enrollment: 49 (actual)

## Conditions studied

- Nonalcoholic Fatty Liver Disease
- Nonalcoholic Steatohepatitis
- Bariatric Surgery Candidate
- Obesity, Morbid

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03683589
- **Lead sponsor:** University of Missouri-Columbia
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-02-01
- **Primary completion:** 2019-08-21
- **Final completion:** 2020-07-31
- **Target enrollment:** 49 (ACTUAL)
- **Last updated:** 2024-12-19

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03683589

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03683589, "De Novo Lipogenesis in Severity of NAFLD". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03683589. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*